Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

January 2011 - FRMC

Feature
01/17/2011
Orlando—In the past few years, the US Food and Drug Administration has approved several therapies to treat lymphoma, including rituximab, tositumomab, bortezomib, vorinostat, bendamustine, and pralatrexate. Recently, medical professionals...
Orlando—In the past few years, the US Food and Drug Administration has approved several therapies to treat lymphoma, including rituximab, tositumomab, bortezomib, vorinostat, bendamustine, and pralatrexate. Recently, medical professionals...
Orlando—In the past few years,...
01/17/2011
First Report Managed Care

Department

News Connection
01/17/2011
To hold insurers accountable when implementing rate increases and help consumers concerned with rising healthcare costs, the Patient Protection and Affordable Care Act (HR 3590) granted states increased authority to review rate increases.
To hold insurers accountable when implementing rate increases and help consumers concerned with rising healthcare costs, the Patient Protection and Affordable Care Act (HR 3590) granted states increased authority to review rate increases.
To hold insurers accountable...
01/17/2011
First Report Managed Care

Advertisement

Advertisement

Advertisement